Vincerx Pharma, Inc. - stock earnings
VINC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -9.7 million USD | ? USD |
| 2023Q2 | -11.2 million USD | ? USD |
| 2023Q1 | -13.6 million USD | ? USD |
| 2022Q4 | -5.5 million USD | ? USD |
| 2022Q3 | -16.9 million USD | ? USD |
| 2022Q2 | -17.2 million USD | ? USD |
| 2022Q1 | -11.2 million USD | ? USD |
| 2021Q4 | -6.5 million USD | ? USD |
| 2021Q3 | -24.5 million USD | ? USD |
| 2021Q2 | -2.0 million USD | ? USD |
| 2021Q1 | -6.3 million USD | 127000 USD |
| 2020Q4 | -10.4 million USD | -1.4 million USD |
| 2020Q3 | -307000 USD | ? USD |
| 2020Q2 | -33000 USD | ? USD |
| 2020Q1 | -4000 USD | ? USD |
| 2019Q4 | -2.7 million USD | ? USD |
VINC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -48.9 million USD | ? USD |
| 2022 | -57.2 million USD | ? USD |
| 2021 | -15.6 million USD | ? USD |
| 2020 | -10.7 million USD | ? USD |
| 2019 | -45000 USD | ? USD |
VINC
Price: $0.89
52 week price:
Earnings Per Share: -1.89 USD
P/E Ratio: -0.68
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 181372
Market Capitalization: 21.0 million